The study's primary aim is * to compare the effects of two different ventilation modalities, non-invasive positive-pressure ventilation (NPPV) and high-flow nasal cannulae (HFNC), in the acute cardiogenic pulmonary edema (ACPE) setting, in terms of echocardiographic parameters of RV systolic and RV strain. * to determine the differences of the two interventions on other hemodynamic parameters echocardiographically assessed. * to assess the differences between the two interventions on physiological parameters, i.e., mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), oxygen saturation (SpO2), and on arterial blood gases (ABG) analysis parameters (i.e. relief of dyspnea and respiratory distress, patient comfort). Enrolled patients will receive NPPV and HFNC oxygen therapy in a randomized, cross-over fashion, for 40 minutes each (time 0, T0 and time 1, T1), followed by clinical and echocardiographic evaluation
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
RV systolic function: Tricuspid annular plane systolic excursion (TAPSE), mm
Timeframe: T0 (Patient's enrollment time)
RV systolic function: Tricuspid annular plane systolic excursion (TAPSE), mm
Timeframe: T1 (40 minutes after the first intervention has started)
RV systolic function: Tricuspid annular plane systolic excursion (TAPSE), mm
Timeframe: T2 (40 minutes after the second intervention has started)
RV systolic function: RV fractional area change (RVFAC), %
Timeframe: T0 (Patient's enrollment time)
RV systolic function: RV fractional area change (RVFAC), %
Timeframe: T1 (40 minutes after the first intervention has started)
RV systolic function: RV fractional area change (RVFAC), %
Timeframe: T2 (40 minutes after the second intervention has started)
RV systolic function: RV Global Longitudinal strain (GLS), %
Timeframe: T0 (Patient's enrollment time)
RV systolic function: RV Global Longitudinal strain (GLS), %
Timeframe: T1 (40 minutes after the first intervention has started)
RV systolic function: RV Global Longitudinal strain (GLS), %
Timeframe: T2 (40 minutes after the second intervention has started)